Methotrexate in paediatric ulcerative colitis: A retrospective survey at a single tertiary referral centre

Alimentary Pharmacology and Therapeutics

Volumn 32, Issue 8, 2010, Pages 1017-1022

  Aloi, M ^a   Di Nardo, G ^a   Conte, F ^a   Mazzeo, L ^a   Cavallari, N ^a   Nuti, F ^a   Cucchiara, S ^a   Stronati, L ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ENEA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; FOLIC ACID; MESALAZINE; METHOTREXATE; PREDNISOLONE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; DISEASE ACTIVITY; DRUG DOSE REDUCTION; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG USE; DRUG WITHDRAWAL; FEMALE; HEMATOLOGIC DISEASE; HUMAN; INFECTIOUS COMPLICATION; LONGITUDINAL STUDY; MALE; NAUSEA; OUTCOME ASSESSMENT; PATIENT REFERRAL; PRIORITY JOURNAL; RELAPSE; REMISSION; RETROSPECTIVE STUDY; SCHOOL CHILD; SCORING SYSTEM; SIDE EFFECT; SPONDYLOARTHROPATHY; TREATMENT RESPONSE; ULCERATIVE COLITIS;

ADOLESCENT; ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; ANTIMETABOLITES, ANTINEOPLASTIC; CHILD; COLITIS, ULCERATIVE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; METHOTREXATE; REMISSION INDUCTION; RETROSPECTIVE STUDIES;

EID: 77957238090     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04433.x     Document Type: Article

References (38)

1. Grossman AB, Baldassano RN. Specific considerations in the treatment of pediatric inflammatory bowel disease. Expert Rev Gastroenterol Hepatol 2008 2: 105 124.
2. Sauer CG, Kugathasan S. Pediatric inflammatory bowel disease: highlighting pediatric differences in IBD. Med Clin North Am 2010 94: 35 52.
3. Hyams J, Markowitz J, Lerer T, et al. The natural history of corticosteroid therapy for ulcerative colitis in children. Clin Gastroenterol Hepatol 2006 4: 1118 1123. (Pubitemid 44311638)
4. Leonard MB. Glucocorticoid-induced osteoporosis in children: impact of the underlying disease. Pediatrics 2007 119: S166 72.
5. Rufo PA, Bousvaros A. Current therapy of inflammatory bowel disease in children. Paediatr Drugs 2006 8: 279 302. (Pubitemid 44607534)
6. Punati J, Markowitz J, Leret T, et al. Effect of early immunomodulator use in moderate to severe pediatric Crohn's disease. Inflamm Bowel Dis 2008 14: 949 954.
7. Braus NA, Elliott DE. Advances in the pathogenesis and treatment of IBD. Clin Immunol 2009 132: 1 9.
8. Homan M, Baldassano RN, Mamula P. Managing complicated Crohn's disease in children and adolescents. Nat Clin Pract Gastroenterol Hepatol 2005 2: 572 579.
9. Akoberg AK. Crohn's disease: current treatment options. Arch Dis Child 2008 93: 787 792.
10. Kandiel A, Fraser AG, Korelitz BI, Brensinger C, Lewis JD. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut 2005 54: 1121 1125. (Pubitemid 41025906)
11. Cucchiara S, Escher J, Hildebrand H, Amil-Dias J, Stronati L, Ruemmele FM. Pediatric inflammatory bowel disease and risk of lymphoma: should we revise our treatment strategies? J Pediatr Gastroentyerol Nutr 2009 48: 257 267.
12. Jolivet J, Cowan KH, Curt GA, Clendeninn NJ, Chabner BA. The pharmacology and clinical use of methotrexate. N Engl J Med 1983 309: 1094 1104. (Pubitemid 13023161)
13. Cronstein BN. The mechanism of action of methotrexate. Rheumat Dis Clin North AM 1997 23: 739 755.
14. Feely MG, Erickson A, O'Dell Jr. Therapeutic options for rheumatoid arthritis. Expert Opin Pharmacother 2009 10: 2095 2106.
15. Kalb RE, Strober B, Weinstein G, Lebwohl M. Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference. J Am Acad Dermatol 2009 60: 824 837.
16. Kozarek RA, Patterson DJ, Gelfand MD, Botoman VA, Ball TJ, Wilske KR. Methotrexate induces clinical and hystologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med 1989 110: 353 356.
17. Feagan BG, Rochon J, Fedorak RN, et al. Methotrexate in the treatment of Crohn's disease. N Engl J Med 1995 332: 292 297.
18. El-Matary W, Vandermeer B, Griffiths AM. Methotrexate for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2009 3: CD007560.
19. Uhlen S, Belbouad R, Nareski K, et al. Efficacy of methotrexate in pediatric Crohn's disease: a french multicenter study. Inflamm Bowel Dis 2006 12: 1053 1057. (Pubitemid 44665475)
20. Weiss R, Lerner A, Shapiro R, et al. Methotrexate treatment in pediatric Crohn's disease patients intolerant or resistant to purine analogues. J Pediatr Gastroenterol Nutr 2009 48: 526 530.
21. Oren R, Arber N, Odes S, et al. Methotrexate in chronic ulcerative colitis: a double blind, randomised, Israeli multicentre trial. Gastroenterol 1996 110: 1416 1421.
22. Patel V, Macdonald JK, McDonald JW, Chande N. Methotrexate for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2009 4: CD006884. (Pubitemid 351807611)
23. Paoluzi OA, Pica R, Marcheggiano A, et al. Azathioprine or methotrexate in the treatment of patients with steroid dependent or steroid resistant ulcerative colitis: results o fan open-label study on efficacy and tolerability in inducing and maintaining remission. Aliment Pharmacol Ther 2002 16: 1751 1759.
24. Justinich CJ, Hyams JS. Inflammmatory bowel disease in children and adolescence. Gastrointest Endosc Clin N Am, 1994 4: 39 54. (Pubitemid 24009143)
25. Turner D, et al. Development, validation and evaluation of a Pediatric Ulcerative Colitis Activity Index: a Prospective Multicenter Study. Gastroenterol 2007 133: 423 432. (Pubitemid 47193130)
26. Turner D, Seow CH, Greenberg GR, et al. A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis. Clin Gastroenterol Hepatol 2009 7: 1081 1088.
27. Turner D, Hyams J, Markowitz J, et al. Appraisal of the pediatric ulcerative colitis activity index (PUCAI). Inflamm Bowel Dis 2009 15: 1218 1223.
28. Kremer JM, Alarcn GS, Lightfoot RW, et al. Methotrexate for rheumatoid arthritis: suggested guidelines for monitoring liver toxicity. American College of Rheumatology. Arthritis Rheum 1994 37: 316 328.
29. Markowitz J, Grancher K, Kohn N, Daum F. Immunomodulatory therapy for pediatric inflammatory bowel disease: changing patterns of use, 1990-2000. Am J Gastroenterol 2002 97: 928 932. (Pubitemid 34408250)
30. Wahed M, Louis-Auguste JR, Baxter LM, et al. Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine/mercaptopurine. Aliment Pharmacol Ther 2009 30: 614 620.
31. Cummings JRF, Herrlinger KR, Travis SPL, et al. Oral methotrexate in ulcerative colitis. Aliment Pharmacol Ther 2005 21: 285 289.
32. Ravikumara M, Hinsberger A, Spray CH. Role of methotrexate in the management of Crohn's disease. J Pediatr Gastroenterol Nutr 2007 44: 427 430. (Pubitemid 46573224)
33. Morabito L, Montesinos MC, Schreibman DM, et al. Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5′-nucleotidase-mediated conversion of adenine nucleotides. J Clin Invest 1998 101: 295 300. (Pubitemid 28067325)
34. Genestier L, Paillot R, Fournel S, et al. Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells. J Clin Invest 1998 102: 322 328. (Pubitemid 28335191)
35. Nathan DM, Iser JH, Gibson PR. A signle center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration. J Gastroenterol Hepatol 2008 23: 954 958.
36. Pavy S, Constantin A, Pham T, et al. Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion. Joint Bone Spine 2006 73: 388 395. (Pubitemid 44056248)
37. Aberra FN, Lichtenstein GR. Monitoring of inflammatory bowel disease. Aliment Pharmacol Ther 2005 21: 307 319.
38. Siegel CA, Sands BE. Review article: practical management of inflammatory bowel disease patients taking immunomodulators. Aliment Pharmacol Ther 2005 22: 1 16.